Editorial comment on: Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy.
Lopez-Beltran
Antonio
A
Montironi
Rodolfo
R
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D055252:Cell-Derived Microparticles / Q000187:drug effects*; D000077143:Docetaxel; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D043823:Taxoids / Q000494:pharmacology* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel